The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.
Selecting anti-Zika virus drug leads able to translocate the blood-placental and blood-brain barriers. Combining innovative and effective translocating peptides with new antivirals to target Zika across barriers. Carla Iris Cadima Couto, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €239,303.